chrisvoncsefalvay/vaers-outcomes huggingface dataset:
15 minutes after vaccination, Patient  complained of non-radiating chest pain  and "stomach discomfort."  States chest pain  3-4 out of 10.  Vital signs stable.  Denies nausea or pain in other areas.  States "a little" short of breath.  Unable to determine pulse ox related to client nail polish.  911 was called, paramedics recommended client go for hospital evaluation, client refused.  Client walked out with her husband.  She was encouraged multiple times to go for evaluation, and to call her doctor to report symptoms.
syncope two hours after the vaccine.; This is a spontaneous report from a contactable other hcp (patient). A 35-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot Number: ew0151), via an unspecified route of administration, administered in Arm Right on 11Apr2021 13:00 (at 35-year-old) as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient was not pregnant.  Vaccination facility type was Pharmacy or Drug Store. Patient had no covid prior vaccination. Patient was not tested for covid post vaccination. Patient had no known allergies. The patient experienced syncope two hours after the vaccine on 11Apr2021 15:00, she never had any history of syncope before. No treatment was received. The outcome of the event was recovered in Apr2021.
Within 12 hours of receiving my first covid 19 vaccine I had a bulging eye.
This spontaneous report was received from a registered nurse referring to unspecified number of patients of unknown age and gender. The patient's medical history or concurrent condition were not provided. On unknown dates, the patients were vaccinated with doses of PNEUMOVAX 23 (lot # L012042, expired date as 18-NOV-2016, route, dose, dose number and strength were unspecified) that were improperly stored. No adverse effects were reported. This is one of the two reports that received from the same source. Additional information has been requested.
Headache, Myalgia, Fever, fatigue, injection site swelling redness; tenderness extending to axilla area Narrative: Fever, headache, myalgia, fatigue, injection site sw3elling, redness. Tenderness extending to the axilla area. Resulted in unable to work 3/24 and 3/25/2021.
78 y.o female arrived on site stating  she was there for her second dose of Pfizer. Pt answered "no" to all screening questions with registration, vaccine tech and vaccinator, indicating she was not a high risk patient. Vaccinator administered dose. During this time, vaccine tech noted that vaccine card had 2 vaccinations noted on it and that third dose was just administered. Pt was directed to observation and observed for 30 minutes.  Pt was alert with no adverse reaction noted.  Pt was notified that the third dose was not supposed to be given and explained potential side effects.  Pt states understanding and ambulated out of the clinic.
Patient fully vaccinated for COVID, but hospitalized  on 9/22/21 for acute COVID illness
The vaccination was administered around 11:24 am The incident was after patient used the inhaler (combivent). patient was having difficulty breathing. patient took the rescue inhaler albuterol HFA. Patient had experienced anaphylaxis around 2:30 pm patient went to the Er (minor emergency). Patient was slurring, forceful vomiting, breathing heavy. HR was about patient was given steroid, Benadryl and nebulization treatment. (2 treatments)
Woke up got up to go to restroom and felt very faint, went the bathroom my husband helped me get back to bed.  I laid down and in a few minutes I started to feel nauseous and started getting severe pain all over my torso, arms radiating to my neck and jaw called 911 I wanted to eliminate possibility of heart attack.  Emergency Tech. took vitals and they were all ok to decided to remain at home. Pains lasted for 4-5 hrs. took Advil and my husband gave me strong massages throughout this period.  When pain subsided I dozed for a little bit and then when I woke up pains started again but not as aggressive, slowly pain subsided jaw pain kept coming back through the next day.  The next day I was very weak when I excepted myself at all I would start to feel faint by the evening I started to feel better. The third day Friday I felt better still a bit tired. Today Sunday I feel ok but still not 100%.
Abdominal discomfort. Uncontrolled and increasing Blood pressure Uncontrolled and increasing blood glucose levels
yellow fever vax 1030 periorbital angioedema, pruritis fu llness in throat;
BUT THEY DO KILL MY MOM; This spontaneous report received from a consumer via social media via a company representative concerned a female of unspecified age, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported, 1 total was administered for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient died from unknown cause of death. The reporter reported that, "But they DO kill my Mom. Looking at YOU at pfizer at moderna tx at social media. Keep peddling your poison." It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of but they do kill my mom was fatal. This report was serious (Death).; Sender's Comments: V0: 20220322463-covid-19 vaccine ad26.cov2.s-  But they do kill my mom (Death). The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
Pfizer covid 19 vaccine vial was mixed with 1.4 instead of 1.8 ml of diluent and patient received a dose. Spoke to patient's wife 04/10/2021 and she stated patient was feeling fine. I provided counseling regarding possible side effects and what to do if he experiences any.
Information has been received from a registered nurse referring to an unspecified number of patients of unknown age and gender. No concurrent or medical history was reported. On unspecified dates the patients were administered unspecified number of improperly stored doses of M-M-R II (lot number J006137, expiration date 24-MAY-2015 and lot number K008814, expiration date 19-JUN-2016) (strength, route and dose were unknown). No adverse event was reported.  Follow up information has been receive from the registered nurse on 27-JUL-2015 concerning a patient of unknown age and gender. On 29-APR-2015, the patient was vaccinated with an improperly stored dose of M-M-R II (lot# J006137, expiration date: 24-MAY-2015, strength, route and dose were unknown). This is one of several reports received from the same reporter. Additional information has been requested.
The worst symptom was a severe headache. That lasted for 2 days. Once that went away, everything got significantly better. I felt tired and achy, still feeling tired even today. I had mild congestion but no fever, no loss of taste or smell. The headache was the worst part of it. I isolated and wore a mask around the house to protect my wife. I'm currently on day 8 and she has not been affected. I considered the option of PAXLOVID, but by the time I had the prescription, my symptoms were already drastically improving. I took vitamin C, vitamin D, and zinc and stayed hydrated which were all suggested during my telehealth visit. I do feel better except just a little bit of tiredness. I did an at home COVID-19 test 03/20/2023 which was positive. I retook another test yesterday 03/26/2023 which was also positive. My wife has been taking the same tests and she's come up negative every time, so I'm confident in the results of these COVID-19 tests.
The shots were two years apart; This case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (received 1st dose in July 2020).   In August 2022, the patient received the 2nd dose of Shingles vaccine. In August 2022, unknown after receiving Shingles vaccine, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK Receipt Date: 05 DEC 2022 Reporter's comment: This case was reported by a patient via interactive digital media. The patient reported that the patient received 1st dose in July 2020, then went on a different insurance plan and they would not pay for the second shot. The patient went on this year and got the second shot.  But the pharmacist said the shots were too far apart and the patient had to have both shots again. The patient went for the second shot on the day of reporting and a different pharmacist said  he/she didn'tneed the second shot since he/she had two even though they were two years apart. The patient asked who was right. The patient had not any side effects. Additional supportive information: As patient received 2nd dose 2 years after 1st dose which led to lengthening of vaccination schedule.
Rebound COVID symptoms; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (Rebound COVID symptoms) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033F21A) for COVID-19 vaccination.    Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19 treatment.    The patient's past medical history included GERD and Anxiety. Concurrent medical conditions included Soy allergy (Soy), Penicillin allergy (Penicillin) and Drug allergy. Concomitant products included GUAIFENESIN from 12-May-2022 to 15-May-2022 for an unknown indication.   On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-May-2022, the patient started NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. On 23-May-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (Rebound COVID symptoms). At the time of the report, COVID-19 (Rebound COVID symptoms) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient was taking other medication within 2 weeks of starting COVID-19 treatment. Patient reported that she had rebound of COVID-19 symptoms.  No treatment information was provided.  Device date was 24-May-2022.  Company comment: This spontaneous case concerns a 27-year-old female patient with no relevant medical history reported, who experienced the unexpected non-serious AESI event of COVID-19,which occurred  168 after receiving third dose of mRNA-1273 vaccine. It was reported that patient was treated with Paxlovid from 13-may-2022 to 17-may-2022. She was tested positive 6 days after the treatment with Paxlovid, The current pandemic situation of COVID 19 may remain as confounder to the event Covid-19.  The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: Company comment: This spontaneous case concerns a 27-year-old female patient with no relevant medical history reported, who experienced the unexpected non-serious AESI event of COVID-19,which occurred  168 after receiving third dose of mRNA-1273 vaccine. It was reported that patient was treated with Paxlovid from 13-may-2022 to 17-may-2022. She was tested positive 6 days after the treatment with Paxlovid, The current pandemic situation of COVID 19 may remain as confounder to the event Covid-19.  The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
The second day after my injection I began to have a rash. It started on my face effecting my eyes and spread to my neck, both forearms, both hands, the right side of my stomach down to my right thigh, my right shin and my left foot. The rash has cleared up about 2 weeks after the vaccination but I still feel an itching sensation in the areas that I had a rash from time to time throughout the day.
pt recv vax & 2wk p/vax pt devel full blown chickenpox;
incomplete dose administered; Initial information received on 21-Feb-2022 regarding an unsolicited valid non-serious case received from a other health professional via call center.  This case involves a 2 months old male patient who experienced incomplete dose administered while receiving vaccine diphtheria/tetanus/5 hybrid ac pertussis/IPV(MRC5)/HIB(PRP/T) vaccine [Pentacel].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included pneumococcal vaccine CONJ 7V (CRM197) (Prevnar) and rotavirus vaccine (Rotavirus vaccine) for Immunization.  On 12-Oct-2021, the patient received a first 0.5 ml dose of suspect diphtheria/tetanus/5 hybrid ac pertussis/IPV(MRC5)/HIB(PRP/T) vaccine lot UJ571AA via unknown route in the left thigh (dosage form, strength, formulation and expiry date: unknown). On 21-Feb-2022 he also received a second 0.5 ml dose of the same vaccine lot UJ527AA via unknown route in the left thigh (dosage form, strength, formulation and expiry date: unknown) for immunization.  On 12-OCT-2021, the patient developed a non-serious event incomplete dose administered (incorrect dose administered) (latency: same day) following the administration of diphtheria/tetanus/5 hybrid ac pertussis/IPV(MRC5)/HIB(PRP/T) vaccine.  Action taken: Not applicable.  It was not reported if the patient received a corrective treatment for the event (incomplete dose administered).  At time of reporting, the outcome was Unknown for the event incomplete dose administered.     This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Erythemia multiforme; Rash on her bilateral lower extremities; This case was reported by a other health professional via call center representative and described the occurrence of erythema multiforme in a 86-year-old female patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2019-2020 season) for prophylaxis.   On 18th October 2019, the patient received Fluarix Tetra 2019-2020 season. On 20th October 2019, 2 days after receiving Fluarix Tetra 2019-2020 season, the patient experienced erythema multiforme (serious criteria GSK medically significant) and rash. The patient was treated with benadryl (nos) (Benadryl) and steroids nos (Steroid Pack (Nos)). On an unknown date, the outcome of the erythema multiforme and rash were not recovered/not resolved.   It was unknown if the reporter considered the erythema multiforme and rash to be related to Fluarix Tetra 2019-2020 season.  Additional details were provided as follows: The patient had a rash on her bilateral lower extremities. The patient went to the emergency room and was diagnosed with erythemia multiform. Benadryl and a steroid taper was prescribed to her. The rash had not resolved till the time of reporting. The reporter did not have vaccine information for this adverse event and stated it was administered at another facility. The reporter consented to follow up.
Administrative deviation only; no adverse event resulted from this deviation.  Administrative deviation only; no adverse event resulted from this deviation.  This patient received a mixed series of COVID-19 vaccine (one dose of Moderna and one dose of Pfizer - box #4 above reflects the date of the second dose). The decision to administer a mixed series to the patient was due to an "exceptional circumstance" stemming from the unavailability of the first vaccine product (Moderna) at the time the second dose was This patient received a mixed series of COVID-19 vaccine (one dose of Moderna and one dose of Pfizer - box #4 above reflects the date of the second dose). The decision to administer a mixed series to the patient was due to an "exceptional circumstance" stemming from the unavailability of the first vaccine product (Moderna) at the time the second dose was due.  We understand that although CDC provides considerations for a mixed series in exceptional circumstances (such as a vaccine shortage, which was the case here), a mixed series is still considered an administration deviation that requires VAERS reporting. Note that the date of vaccination on this form reflects the date the patient received his/her second vaccine dose.
Pt developed a fever on 4/17/01. Health Dept contacted 4/18/01 re: pt with fever of 103. Fever did come down with Tylenol. The fever continued all week and went up as far as 105.9. Pt's father contacted hospital ER and was instructed to keep giving Tylenol. Pt did have inconsolable crying during week.
Patient came today 08/10/2021 and reported that she had sweats, chills, vertigo and fall at home one day after receiving 2 nd dose of covid -19 vaccine Moderna.
Single right inguinal lymph node a few days after vaccination noted by parents.   4/19/22 measured by provider: 2.5x1.4cm
Ever since getting the vaccine both of my arms have been hurting. It is hard for me to go to sleep because of it.  I have been to the doctors and they are still trying to figure out what's going on with my arms. I was prescribed gabapentin but that didn't work. Then I was prescribed tramadol which does help me sleep a little bit,  but I am not happy about taking this medicine because I'm not a pill taker.
Hives around location vaccine given within 24 hour period. Lasted 48 hours.
Reported with the first Pfizer COVID vaccine, he had dizziness the next day along with nausea and tiredness which lasted for two to three days. He reported he didn't eat with the first dose of Pfizer COVID vaccine. He denied other signs or symptoms of anaphylaxis. He stated he didn't have a follow-up with PCP and denied any known allergies or any chronic health conditions.
Patient received both doses of shingrix vaccine when he was under the age of 50 years old and did not indicate any immunocompromising conditions.
Late July2021 and 1 Aug2021 - I got sick with diarrhea, fever and nausea, parasite. ER - Aug2021, they to hospital. I still have diarrhea and vomiting. Went to the hospital again and then rehabilitation center. I lost weight. My strength and endurance is bad and I can't walk very far.
Arm pain/numbness, chills, fever, golf sized lump on neck and armpit lump 30 hours later and still,  period very late
19:30 dyspnea, chest tightness, flushing, chills.  20:00 headache, mild dizziness, nausea, tachycardia.  22:00 fever 101.6.  Treated with by mouth Diphenmyoramine.
Rapid heartbeat, shortness of breath and painful heart area.  Her pain level to her was an 8 out of 10.  She was getting very weak and did not feel right so we went to the hospital when she thought she had to go?.
lightheaded; Diarrhoea; can't sleep; threw up once; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (lightheaded), DIARRHOEA (Diarrhoea), INSOMNIA (can't sleep) and VOMITING (threw up once) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included SIMVASTATIN, METFORMIN, PIOGLITAZONE, LISINOPRIL, TAMSULOSIN, INSULIN and PREDNISONE for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced DIARRHOEA (Diarrhoea), INSOMNIA (can't sleep) and VOMITING (threw up once). On 17-Feb-2021, the patient experienced DIZZINESS (lightheaded). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIZZINESS (lightheaded) had not resolved and DIARRHOEA (Diarrhoea), INSOMNIA (can't sleep) and VOMITING (threw up once) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Severe joint pain, myalgias on January 17. Developed fever of 37.9C max, chills and runny nose on January 19. All symptoms resolved by late morning of January 20. Covid test performed on January 20 which was negative.
expired dose of Fluzone HD administered to the patient, no AE; Initial information received on 24-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked to cases 2019SA268361, 2019SA268346, 2019SA268356, 2019SA268357, 2019SA268358, 2019SA268359, 2019SA268360 and 2019SA268362 (same reporter).  This case involves a 90 years old female patient who received 0.5 ml dose of expired vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot UI994AA, Exp. Date 09-Apr-2019) via intramuscular route in the right deltoid, on 13-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was a case of actual medication error due to expired vaccine used.  At the time of reporting, no adverse reactions were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
she did not feel good; she felt achy; FEVERISH; LETHARGY; flu-ish; This is a spontaneous report from a contactable consumer, based on information received by Pfizer (manufacturer control number: EC-2021-087504), for BNT162B2.   A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 06Apr2021 as dose 2, single for COVID-19 immunisation. The patient medical history included allergies (Vicodin, Sulfamethoxazole, Percocet). Concomitant medications included Losartan potassium (MANUFACTURER UNKNOWN) 50 mg tablet, Calcium 500 (1250) (MANUFACTURER UNKNOWN) tablet, Magnesium (MANUFACTURER UNKNOWN) 100 mg tablet, Zinc (MANUFACTURER UNKNOWN) 50 Mg Tablet, Vitamin D3 (MANUFACTURER UNKNOWN) 10 mcg chewable tablet,  Alendronate sodium (FOSAMAX, 70 Mg Tablet), Pembrolizumab (KEYTRUDA, 100mg/4 ml vial), Vitamin B12 (MANUFACTURER UNKNOWN) and Fish oil (OMEGA 3 FISH OILS). Patient also took Lenvima (LENVATINIB MESILATE 4 mg (5 day PK-COMM, Frequency: 1-14 mg/1-10 mg daily, oral, Lot number: 1265566, Expiration date: 30Jun2023) from 11Jan2021. It was reported that, she got her second COVID shot and missed the next day (Lenvima dose). On 06Apr2021, the patient did not feel good, and she felt achy, feverish, lethargy and flu-ish. Physician was aware. The outcome of the events was unknown.  No follow-up attempts needed. No further follow-up information expected.
02/23/2005-Next day headache, dizzyness, weak grip, flu-like symptoms. 02/24/2005- Saw Dr., says better but still had flu-like symptoms.